Peripheral Neuropathy Trial, Recruiting (NCT04273828)

Peripheral Neuropathy Trial, Recruiting NCT04273828 Sponsor: Hospital Israelita Albert Einstein Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT04273828 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have symptoms of nerve compression in the lower back, such as pain, numbness, or weakness spreading down the leg (sometimes called radiculopathy or neurogenic claudication)
People who have tried non-surgical treatments for at least 6 weeks without enough improvement
People who are scheduled to have surgery to relieve nerve pressure in the lower back, such as a discectomy, foraminotomy, or hemilaminectomy (confirm with trial site for exact procedure types)
People who have complete medical records available before and after surgery, covering all required assessments

Who may not be able to join:

People who need spinal fusion surgery (where vertebrae are permanently joined together) as part of their procedure
People who have a deep infection that requires surgical cleaning
People who have had a procedure called facet joint rhizotomy, which involves cutting certain nerves near the spine
People who have an active rheumatological (inflammatory joint or immune system) disease, including certain types of arthritis that do not show specific markers in blood tests

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alberto Gotfryd, PhD, Phisician

Phone: 5511995925225

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04273828

Sponsor: Hospital Israelita Albert Einstein

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 5511995925225

More information: https://clinicaltrials.gov/study/NCT04273828

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have symptoms of nerve compression in the lower back, such as pain, numbness, or weakness spreading down the leg (sometimes called radiculopathy or neurogenic claudication)
People who have tried non-surgical treatments for at least 6 weeks without enough improvement
People who are scheduled to have surgery to relieve nerve pressure in the lower back, such as a discectomy, foraminotomy, or hemilaminectomy (confirm with trial site for exact procedure types)
People who have complete medical records available before and after surgery, covering all required assessments

Who may not be able to join:

People who need spinal fusion surgery (where vertebrae are permanently joined together) as part of their procedure
People who have a deep infection that requires surgical cleaning
People who have had a procedure called facet joint rhizotomy, which involves cutting certain nerves near the spine
People who have an active rheumatological (inflammatory joint or immune system) disease, including certain types of arthritis that do not show specific markers in blood tests

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hospital Israelita Albert Einstein

Registry

ClinicalTrials.gov

Start date

6 April 2020

Est. completion

27 December 2024

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change in Pain Intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov